Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian cancer (HGOC). Meeting Abstract

Industry Collaboration International Collaboration

cited authors

  • Kwan, Tanya; Oza, Amit M.; Lorusso, Domenica; Aghajanian, Carol; Oaknin, Ana; Dean, Andrew Peter; Colombo, Nicoletta; Weberpals, Johanne I.; Clamp, Andrew R.; Scambia, Giovanni; Leary, Alexandra; Holloway, Robert W.; Amenedo, Margarita; Fong, Peter C. C.; Goh, Jeffrey C.; O'Malley, David M.; Maloney, Lara; Goble, Sandra; Ledermann, Jonathan A.; Coleman, Robert L.

Publication Date

  • May 20, 2021

webpage

published in

category

volume

  • 39

issue

  • 15